Stock Rich List
#11797 on the rich list of 14,644 insiders

Gregory T. Lucier

Director at Maravai LifeSciences Holdings; Director at Avantor; Director at DENTSPLY SIRONA. Based in San Diego, California.

$6.7M
in disclosed stock, −$121K (−1.78%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
11797th of 14,644
Companies held
3
Largest holding
MRVI, 45.3% of total
Latest SEC filing
Jun 9, 2026

What the $6.7M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Maravai LifeSciences Holdings MRVI
Class A Common Stock
Indirectly (see filing footnote)156,077$7.19$1.1M16.8%Form 4, Jun 9, 2026
Maravai LifeSciences Holdings MRVI
Class A Common Stock
Directly155,123$7.19$1.1M16.7%Form 4, Jun 9, 2026
Avantor AVTR
Common Stock
Indirectly (see filing footnote)60,000$15.12$907K13.6%Form 4, May 8, 2026
Maravai LifeSciences Holdings MRVI
Class A Common Stock
Through Family Partnership109,784$7.19$789K11.8%Form 4/A, May 26, 2026
Avantor AVTR
Common Stock
Through a Trust50,000$15.12$756K11.3%Form 4, Feb 19, 2026
DENTSPLY SIRONA XRAY
Common Stock
Through a Trust65,000$8.49$552K8.3%Form 4, Jun 3, 2026
DENTSPLY SIRONA XRAY
Common Stock
Indirectly (see filing footnote)63,283$8.49$537K8.0%Form 4, Jun 3, 2026
Avantor AVTR
Common Stock
Directly34,006$15.12$514K7.7%Form 4, May 7, 2026
DENTSPLY SIRONA XRAY
Common Stock
Through Family Partnership24,901$8.49$211K3.2%Form 4, Mar 9, 2026
DENTSPLY SIRONA XRAY
Common Stock
Through Gregory Lucier IRA21,000$8.49$178K2.7%Form 4, Jun 3, 2026

Share counts are the amounts Gregory T. Lucier reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
May 8, 2026BoughtAVTR10,000$8.32$83KView
Mar 9, 2026BoughtXRAY15,000$12.45$187KView
Mar 3, 2026BoughtXRAY22,445$14.03$315KView
Mar 2, 2026BoughtXRAY27,555$14.25$393KView
Feb 19, 2026BoughtAVTR50,000$9.16$458KView
Dec 8, 2025BoughtMRVI48,528$3.67$178KView
Dec 8, 2025SoldXRAY82,200$11.14$916KView
Dec 5, 2025BoughtMRVI51,472$3.70$190KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
11794Mahesh Narang
Insider, Oshkosh. Oshkosh, WI
$6.7M−$95K (−1.41%)
11795Anh Tu Nguyen
See Remarks, Xeris Biopharma Holdings. Chicago, IL
$6.7M−$149K (−2.18%)
11796Ruth G. Shaw
Director, SPX Technologies. Charlotte, NC
$6.7M−$50K (−0.74%)
11797Gregory T. Lucier
Director, Maravai LifeSciences Holdings. San Diego, CA
$6.7M−$121K (−1.78%)
11798Anthony J. DiCiollo
Head of Institutional Segment, StoneX Group. New York, NY
$6.7M−$2.4M (−26.71%)
11799Mark J. Erceg
Chief Financial Officer, Newell Brands. Atlanta, GA
$6.7M−$321K (−4.59%)
11800Eric A. Fisher
SVP, Valero Energy. San Antonio, TX
$6.7M−$103K (−1.52%)

Other Maravai LifeSciences Holdings insiders

All MRVI insiders

Questions

How much stock does Gregory T. Lucier own?

Gregory T. Lucier holds $6,683,073 in listed stock based on SEC filings and current prices, mostly Maravai LifeSciences Holdings (MRVI). That ranks 11797th on the Stock Rich List.

Is this Gregory T. Lucier's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Gregory T. Lucier last buy or sell stock?

The most recent open-market trade on file is a purchase of 10,000 AVTR shares on May 8, 2026 at $8.32.